Company intelligence / Profile preview

Allovate Therapeutics

New York City, New York, United Statesallovate.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Allovate Therapeutics has developed a novel oral mucosal immunotherapy platform for allergy treatment. Their lead product integrates allergen-specific immunotherapeutic agents into a toothpaste base ("Allerdent"), allowing patients to receive daily allergy immunotherapy during routine tooth brushing. This approach aims to improve convenience and adherence while reducing the risk of adverse reactions compared to traditional injection-based therapies. Clinical investigations are ongoing for both food and respiratory allergies; no pivotal or late-stage clinical results have been published yet

Therapeutic areas: Immunology
Modalities: ProteinRecombinant proteinDevice (toothpaste-based delivery platform)
Industry: Biotech

Drug pipeline

1 asset

Allerdent

Unknown

Partnerships

Intrommune Therapeutics – licensee developing applications of the technology for life-threatening food allergies

Beyond the preview

Go deeper on Allovate Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allovate Therapeutics.